Clinical Edge Journal Scan

Male infertility and breast cancer: Is there a link?


 

Key clinical point: Male-origin infertility was associated with an increased risk for breast cancer (BC) in men.

Major finding: Risk for BC was significantly higher in men diagnosed with infertility (odds ratio [OR] 2.03; P = .01), those diagnosed with infertility or low sperm count (OR 2.17; P = .004), and those who had not fathered any children (OR 1.50; P < .001).

Study details: Findings are from a case-control study including 1998 men diagnosed with in situ or invasive BC at <80 years of age and 1597 matched male controls.

Disclosures: This study was supported by Breast Cancer Now, formerly Breakthrough Breast Cancer, and the John Tridgell family. The authors declared no conflicts of interest.

Source: Swerdlow AJ et al. Infertility and risk of breast cancer in men: a national case–control study in England and Wales. Breast Cancer Res. 2022;24:29 (May 17). Doi: 10.1186/s13058-022-01517-z

Recommended Reading

Metastatic lobular, ductal cancers respond similarly
MDedge Hematology and Oncology
This breast tumor subtype disproportionately affects Black women
MDedge Hematology and Oncology
Breast cancer less common in Black women, so why do more die?
MDedge Hematology and Oncology
Primary BC: Weekly vs. every-3-week nab-paclitaxel improves pCR but with higher toxicity
MDedge Hematology and Oncology
Advanced TNBC: Camrelizumab + apatinib and eribulin shows promise in heavily pretreated patients
MDedge Hematology and Oncology
Metformin disappoints in high-risk operable breast cancer
MDedge Hematology and Oncology
Elacestrant prolongs survival in previously treated ER+/HER2− advanced BC
MDedge Hematology and Oncology
Adjuvant radiotherapy less toxic in prone vs. supine position in BC patients with heavy breasts
MDedge Hematology and Oncology
Metastatic BC and brain metastases: Etirinotecan pegol fails to improve survival in phase 3
MDedge Hematology and Oncology
Breast cancer: Epigallocatechin-3-gallate prevents dermatitis in patients receiving radiotherapy
MDedge Hematology and Oncology